Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Alfred Ian Lee

Alfred Ian Lee


Academic history

Alfred Ian Lee, MD, PhD, is an Associate Professor of Medicine, and the Director of the Hematology/Oncology Fellowship Program, at the Yale School of Medicine, New Haven, CT. Dr Lee received his MD and PhD from the Yale School of Medicine and completed residency in internal medicine at Brigham & Women’s Hospital, Boston, MA, where he was appointed as Chief Medical Resident. Following this he complete a fellowship in hematology/oncology at the Dana-Farber Cancer Institute, Boston, MA.

Dr Lee is an active member of the National Comprehensive Cancer Network Cancer-Associated Venous Thromboembolic Disease Panel and NIH ClinGen Hemostasis/Thrombosis Expert Panel, as well as being the Chair of the Recruitment & Retention Working Group at the American Society of Hematology. He has received awards such as the Charles W. Bohmfalk Prize and Leah M. Lowenstein Award for excellence in teaching and education, and the David J. Lefell Prize for Clinical Excellence.

Speaking on COVID-19, thrombosis, and anticoagulation drugs

Dr Lee has co-authored several peer reviewed research papers, the latest of which are focused on the challenges that the COVID-19 pandemic has caused in the fields of thrombosis and anticoagulant drug development. His recent research involves studying the effects of vaccination on cerebral venous sinus thrombosis, the association of obesity with venous thromboembolism in COVID-19, and the effect of COVID-19 on immunothrombosis.